Cargando…

CD14(bright)CD16+ intermediate monocytes are induced by interleukin-10 and positively correlate with disease activity in rheumatoid arthritis

BACKGROUND: Three different subsets of circulating human monocytes, CD14(bright)CD16- (classical), CD14(bright)CD16+ (intermediate), and CD14(dim)CD16+ (non-classical) have been recently identified. It has been reported that CD14(bright)CD16+ monocytes are increased in rheumatoid arthritis (RA). How...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tsukamoto, Masako, Seta, Noriyuki, Yoshimoto, Keiko, Suzuki, Katsuya, Yamaoka, Kunihiro, Takeuchi, Tsutomu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5301443/ https://www.ncbi.nlm.nih.gov/pubmed/28183329 http://dx.doi.org/10.1186/s13075-016-1216-6

Ejemplares similares

Longitudinal immune cell monitoring identified CD14(++) CD16(+) intermediate monocyte as a marker of relapse in patients with ANCA-associated vasculitis
por: Matsumoto, Kotaro, et al.
Publicado: (2020)

Circulating CD14(bright)CD16(+) ‘Intermediate’ Monocytes Exhibit Enhanced Parasite Pattern Recognition in Human Helminth Infection
por: Turner, Joseph D., et al.
Publicado: (2014)

A new bioassay for measuring the strength of IL-6/STAT3 signal inhibition by tocilizumab in patients with rheumatoid arthritis
por: Saito, Shuntaro, et al.
Publicado: (2017)

Peripheral blood CD4(+)CD25(+)CD127(low) regulatory T cells are significantly increased by tocilizumab treatment in patients with rheumatoid arthritis: increase in regulatory T cells correlates with clinical response
por: Kikuchi, Jun, et al.
Publicado: (2015)

The “Intermediate” CD14(++)CD16(+) monocyte subset increases in severe peripheral artery disease in humans
por: Wildgruber, Moritz, et al.
Publicado: (2016)

CTRP3 induces an intermediate switch of CD14(++)CD16(+) monocyte subset with anti-inflammatory phenotype
por: Zhu, Hongtao, et al.
Publicado: (2020)

Restoration of Decreased T Helper 1 and CD8+ T Cell Subsets Is Associated With Regression of Lymphoproliferative Disorders Developed During Methotrexate Treatment
por: Saito, Shuntaro, et al.
Publicado: (2018)

Elevated circulating CD14(++)CD16(+) intermediate monocytes are independently associated with extracardiac complications after cardiac surgery
por: Mossanen, Jana C., et al.
Publicado: (2020)

The “Intermediate” CD14 + CD16 + monocyte subpopulation plays a role in IVIG responsiveness of children with Kawasaki disease
por: Kim, Yi Seul, et al.
Publicado: (2021)

CD14+CD16+ and CD14+CD163+ monocyte subpopulations in kidney allograft transplantation
por: Sekerkova, Alena, et al.
Publicado: (2014)

CD14(high)CD16(+) monocytes are the main producers of Interleukin-10 following clinical heart transplantation
por: Ludwig, Kristina, et al.
Publicado: (2023)

Elevated expression of BAFF receptor, BR3, on monocytes correlates with B cell activation and clinical features of patients with primary Sjögren’s syndrome
por: Yoshimoto, Keiko, et al.
Publicado: (2020)

Multiomic disease signatures converge to cytotoxic CD8 T cells in primary Sjögren’s syndrome
por: Tasaki, Shinya, et al.
Publicado: (2017)

CD14(+)CD16(−) monocytes are the main precursors of osteoclasts in rheumatoid arthritis via expressing Tyro3TK
por: Xue, Jimeng, et al.
Publicado: (2020)

Mesangiogenic Progenitor Cells Derived from One Novel CD64(bright)CD31(bright)CD14(neg) Population in Human Adult Bone Marrow
por: Pacini, Simone, et al.
Publicado: (2016)

CD14+ monocytes and soluble CD14 of synovial fluid are associated with osteoarthritis progression
por: Lee, Ha-Reum, et al.
Publicado: (2022)

Increased Interleukin-35 suppresses peripheral CD14(+) monocytes function in patients with Kawasaki disease
por: Xing, Haijian, et al.
Publicado: (2020)

Regulatory mechanisms for the production of BAFF and IL-6 are impaired in monocytes of patients of primary Sjögren's syndrome
por: Yoshimoto, Keiko, et al.
Publicado: (2011)

ADAM17-Mediated Reduction in CD14(++)CD16(+) Monocytes ex vivo and Reduction in Intermediate Monocytes With Immune Paresis in Acute Pancreatitis and Acute Alcoholic Hepatitis
por: Waller, Kathryn, et al.
Publicado: (2019)

The CD14 (−159 C/T) SNP is associated with sCD14 levels and allergic asthma, but not with CD14 expression on monocytes
por: Nieto-Fontarigo, J. J., et al.
Publicado: (2018)

Elevated Fibronectin Levels in Profibrotic CD14(+) Monocytes and CD14(+) Macrophages in Systemic Sclerosis
por: Rudnik, Michał, et al.
Publicado: (2021)

Circulating CD14(high) CD16(low) intermediate blood monocytes as a biomarker of ascites immune status and ovarian cancer progression
por: Prat, Mélissa, et al.
Publicado: (2020)

Changes in the Monocytic Subsets CD14(dim)CD16(+) and CD14(++)CD16(−) in Chronic Systolic Heart Failure Patients
por: Amir, Offer, et al.
Publicado: (2012)

Clinical and Immunological Features of Anti-centromere Antibody-Positive Primary Sjögren’s Syndrome
por: Tsukamoto, Masako, et al.
Publicado: (2018)

CD14CD16 Monocyte Subset Levels in Heart Failure Patients
por: Barisione, Chiara, et al.
Publicado: (2010)

Characterization of the CD14(++)CD16(+) Monocyte Population in Human Bone Marrow
por: Mandl, Manuela, et al.
Publicado: (2014)

Distinct gene expression patterns for CD14++ and CD16++ monocytes in preeclampsia
por: Vishnyakova, Polina, et al.
Publicado: (2022)

Elevated Numbers of Circulating Very Small Embryonic-Like Stem Cells (VSELs) and Intermediate CD14++CD16+ Monocytes in IgA Nephropathy
por: Eljaszewicz, Andrzej, et al.
Publicado: (2018)

Intermediate CD14(++)CD16(+) monocytes decline after transcatheter aortic valve replacement and correlate with functional capacity and left ventricular systolic function
por: Neuser, Jonas, et al.
Publicado: (2017)

Peripheral TIGIT+ T Follicular Helper Cells That Produce High Levels of Interleukin-21 via OX40 Represent Disease Activity in IgG4-Related Disease
por: Akiyama, Mitsuhiro, et al.
Publicado: (2021)

Circulating CD14(+) monocytes in patients with aortic stenosis
por: Shimoni, Sara, et al.
Publicado: (2016)

CD169 Defines Activated CD14(+) Monocytes With Enhanced CD8(+) T Cell Activation Capacity
por: Affandi, Alsya J., et al.
Publicado: (2021)

The CD14(+/low)CD16(+) monocyte subset is more susceptible to spontaneous and oxidant-induced apoptosis than the CD14(+)CD16(−) subset
por: Zhao, C, et al.
Publicado: (2010)

CD32 is enriched on CD4(dim)CD8(bright) T cells
por: Virdi, Amber K., et al.
Publicado: (2020)

The involvement of CD14 in the activation of human monocytes by peptidoglycan monomers.
por: Muhvić, D, et al.
Publicado: (2001)

A Higher Frequency of CD14(+)CD169(+) Monocytes/Macrophages in Patients with Colorectal Cancer
por: Li, Chenguang, et al.
Publicado: (2015)

Glycolysis Is Required for LPS-Induced Activation and Adhesion of Human CD14(+)CD16(−) Monocytes
por: Lee, Man K. S., et al.
Publicado: (2019)

Author Correction: Distinct gene expression patterns for CD14++ and CD16++ monocytes in preeclampsia
por: Vishnyakova, Polina, et al.
Publicado: (2022)

Multi-omics monitoring of drug response in rheumatoid arthritis in pursuit of molecular remission
por: Tasaki, Shinya, et al.
Publicado: (2018)

Distinct gene signatures of monocytes and B cells in patients with giant cell arteritis: a longitudinal transcriptome analysis
por: Matsumoto, Kotaro, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_0g7jlogn9af6kkn19fhcumhsh4